ALERT: UNILATERAL PRACTICE - LICENCE - PARENT - ROYALTIES - ANNULMENT

Preliminary ruling: The Court of Justice of the European Union rules that article 101(1) TFEU must be interpreted as not precluding the imposition on the licensee, under a licence agreement such as that at issue in the main proceedings, of a requirement to pay a royalty for the use of a patented technology for the entire period in which that agreement was in effect, in the event of the revocation or non-infringement of a licenced patent, provided that the licensee was able freely to terminate that agreement by giving reasonable notice (Genetech/Hoechst/Sanofi)

Le 7 juillet 2016, la Cour de justice de l'Union a rendu un arrêt dans l'affaire C-567/14 (Genentech Inc. / Hoechst GmbH, anciennement Hoechst AG, Sanofi-Aventis Deutschland GmbH). Il s'agit d'une demande de décision préjudicielle présentée par la Cour d'appel de Paris le 9 décembre 2014. Cette affaire s'inscrit dans le cadre d’un recours en annulation des sentences arbitrales opposant Genentech Inc., société de droit du Delaware, aux sociétés pharmaceutiques Hoechst et Sanofi-Aventis. En 1992, la société allemande Behringwerke AG, ultérieurement reprise par la société allemande Sanofi-Aventis Deutschland, a concédé à Genentech une licence non exclusive mondiale pour l’utilisation d'un activateur permettant d’accroître l’efficacité du processus cellulaire utilisé pour la fabrication de protéines. Cette

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Preliminary ruling: The Court of Justice of the European Union rules that article 101(1) TFEU must be interpreted as not precluding the imposition on the licensee, under a licence agreement such as that at issue in the main proceedings, of a requirement to pay a royalty for the use of a patented technology for the entire period in which that agreement was in effect, in the event of the revocation or non-infringement of a licenced patent, provided that the licensee was able freely to terminate that agreement by giving reasonable notice (Genetech/Hoechst/Sanofi), 7 July 2016, Concurrences Review Nº 4-2016, Art. N° 82231, www.concurrences.com

Visites 131

All reviews